September 16, 2020

Webinar: 5 Years of ICER - Insights and Impact on Payers

By Xcenda

Payers are increasingly reliant on ICER reports for their formulary decision-making process.

Topics:

Market access Product access Data Commercialization

Is NICE becoming nicer?

Globe with communication lines from UK

Health disparities and health technology assessment: Current value assessment frameworks fall short

Hands holding coins

Equity considerations in US value assessment: Opportunities ahead

abstract lines